Editors: Atta-ur-Rahman , Zareen Amtul

Frontiers in Clinical Drug Research - CNS and Neurological Disorders

Volume 8

eBook: US $69 Special Offer (PDF + Printed Copy): US $117
Printed Copy: US $83
Library License: US $276
ISSN: 2451-8883 (Print)
ISSN: 2214-7527 (Online)
ISBN: 978-981-14-7006-6 (Print)
ISBN: 978-981-14-7008-0 (Online)
Year of Publication: 2020
DOI: 10.2174/97898114700801200801

Introduction

Frontiers in Clinical Drug Research - CNS and Neurological Disorders is a book series that brings updated reviews to readers interested in advances in the development of pharmaceutical agents for the treatment of central nervous system (CNS) and other nerve disorders. The scope of the book series covers a range of topics including the medicinal chemistry, pharmacology, molecular biology and biochemistry of contemporary molecular targets involved in neurological and CNS disorders. Reviews presented in the series are mainly focused on clinical and therapeutic aspects of novel drugs intended for these targets.

Frontiers in Clinical Drug Research - CNS and Neurological Disorders is a valuable resource for pharmaceutical scientists and postgraduate students seeking updated and critical information for developing clinical trials and devising research plans in the field of neurology.

The eighth volume of this series features reviews that cover the following topics related to the treatment of a variety of CNS disorders, related diseases and basic research:

  1. -Emerging Innovative Therapies of Spinal Muscular Atrophy: Current Knowledge and Perspectives
  2. -Obesity Induced by The Neurological Drugs
  3. -Molecular Mechanism of Nervous System Disorders and Implications for New Therapeutic Targets
  4. -Glioma Imaging and Novel Agents
  5. -Screening Models for Neuroleptic Drug-Induced Hyperprolactinemia: A Mini-Review

Contributors

Editor(s):
Atta-ur-Rahman
Kings College
University of Cambridge
Cambridge
UK


Zareen Amtul
The University of Windsor
Department of Chemistry and Biochemistry
Windsor, ON
Canada




Contributor(s):
Betul Cevik
Tokat Gaziosmanpasa University
Faculty of Medicine, Department of Neurology
Tokat
Turkey


Ching H. Wang
Department of Neurology
Driscoll Children's Hospital
Corpus Christi, Texas
USA
/
College of Medicine
Texas A&M University, College Station
Texas
USA


Durdane Aksoy
Tokat Gaziosmanpasa University
Faculty of Medicine, Department of Neurology
Tokat
Turkey


Farhin Patel
Department of Biological Sciences
P. D. Patel Institute of Applied Sciences, Charotar University of Science and Technology, Changa
Anand- 388421, Gujarat
India


Mine Silindir-Gunay
Hacettepe University, Faculty of Pharmacy
Department of Radiopharmacy, 06100, Sıhhiye
Ankara
Turkey


Orhan Sumbul
Tokat Gaziosmanpasa University
Faculty of Medicine, Department of Neurology
Tokat
Turkey


Palash Mandal
Department of Biological Sciences
P. D. Patel Institute of Applied Sciences, Charotar Universityof Science and Technology, Changa
Anand- 388421, Gujarat
India


Prashant Tiwari
School of Pharmacy
School of Health and Allied Sciences, ARKA JAIN University
Jamshedpur -832102
India


Pratap Kumar Sahu
Department of Pharmacology
School of Pharmaceutical Sciences, Siksha O Anusandhan (Deemed to be University)
Bhubaneswar - 751029
India


Semiha Kurt
Tokat Gaziosmanpasa University
Faculty of Medicine, Department of Neurology
Tokat
Turkey


Shweta Shrivastava
School of Pharmacy
School of Health and Allied Sciences, ARKA JAIN University
Jamshedpur -832102
India


Sunil Kumar Dubey
Institute of Pharmacy
Birla Institute of Technology and Science, Pilani
Rajasthan - 333031
India


Tai-Heng Chen
Section of Neurobiology
Department of Biological Sciences, University of Southern California
Los Angeles, California
USA
/
Department of Pediatrics
Kaohsiung Medical University Hospital, Kaohsiung Medical University
Kaohsiung
Taiwan
/
School of Post-Baccalaureate Medicine
College of Medicine, Kaohsiung Medical University
Kaohsiung
Taiwan